Enwei Pharmaceutical: Controlling shareholder releases pledge of 2.92% of shares

Enwei Pharmaceutical Announcement: The controlling shareholder, Chengdu Enwei Investment (Group) Co., Ltd., has解除质押 3 million shares, accounting for 11.66% of its holdings and 2.92% of the company’s total share capital. The pledge started on August 18, 2025, and was解除 on February 4, 2026. The pledgee is Xu Yingzhuang. Enwei Group holds 25,73.32 million shares, accounting for 25.01%. After this解除, its total pledged shares amount to 22.38 million, representing 86.97% of its holdings and 21.75% of the total share capital.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)